The addition of 3-methyladenine (3-MA) to block autophagosome formation via inhibiting type III Phosphatidylinositol 3-kinases had a similar, but lesser effect in CF on LC3 conversion compared to bafilomycin. The gene discussed is MAP1LC3A; the disease is cystic fibrosis.